Patient perspectives on factors influencing active surveillance adherence for low-risk prostate cancer: A qualitative study

被引:1
|
作者
Subramanian, Lalita [1 ]
Hawley, Sarah T. [1 ,2 ]
Skolarus, Ted A. [2 ,3 ]
Rankin, Aaron [1 ]
Fetters, Michael D. [4 ]
Witzke, Karla [5 ]
Chen, Jason [1 ]
Radhakrishnan, Archana [1 ,2 ,6 ]
机构
[1] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA
[2] VA Ann Arbor Healthcare Syst, Ctr Clin Management Res, Hlth Serv Res & Dev, Ann Arbor, MI USA
[3] Univ Chicago, Dept Surg, Urol Sect, Chicago, IL USA
[4] Univ Michigan, Dept Family Med, Ann Arbor, MI 48109 USA
[5] MyMichigan Hlth, Dept Urol, Midland, MI USA
[6] Univ Michigan, Dept Internal Med, Div Gen Med, Internal Med, Ann Arbor, MI 48109 USA
来源
CANCER MEDICINE | 2024年 / 13卷 / 01期
关键词
active surveillance; primary care physicians; prostate cancer; quality of life; trust; urologists; MEN; CRITERIA;
D O I
10.1002/cam4.6847
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundProstate cancer is the most common cancer among men in the United States. Treatment guidelines recommend active surveillance for low-risk prostate cancer, which involves monitoring for progression, to avoid or delay definitive treatments and their side effects. Despite increased uptake, adherence to surveillance remains a challenge.MethodsWe conducted semi-structured, qualitative, virtual interviews based on the Theoretical Domains Framework (TDF), with men (15) who were or had been on active surveillance for their low-risk prostate cancer in 2020. Interviews were transcribed and coded under TDF's behavioral theory-based domains. We analyzed domains related to adherence to surveillance using constructivist grounded theory to identify themes influencing decision processes in adherence.ResultsThe TDF domains of emotion, beliefs about consequences, environmental context and resources, and social influences were most relevant to surveillance adherence-. From these four TDF domains, three themes emerged as underlying decision processes: trust in surveillance as treatment, quality of life, and experiences of self and others. Positive perceptions of these three themes supported adherence while negative perceptions contributed to non-adherence (i.e., not receiving follow-up or stopping surveillance). The relationship between the TDF domains and themes provided a theoretical process describing factors impacting active surveillance adherence for men with low-risk prostate cancer.ConclusionsMen identified key factors impacting active surveillance adherence that provide opportunities for clinical implementation and practice improvement. Future efforts should focus on multi-level interventions that foster trust in surveillance as treatment, emphasize quality of life benefits and enhance patients' interpersonal experiences while on surveillance to optimize adherence. Decision processes related to staying on or stopping active surveillance for prostate cancer involved trust in active surveillance as treatment, quality of life and experiences of self and others. Positive perceptions of these three themes supported adherence while negative perceptions contributed to non-adherence.image
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Adherence to Active Surveillance Protocols for Low-risk Prostate Cancer: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance Initiative
    Kalapara, Arveen A.
    Verbeek, Jan F. M.
    Nieboer, Daan
    Fahey, Michael
    Gnanapragasam, Vincent
    Van Hemelrijck, Mieke
    Lee, Lui Shiong
    Bangma, Chris H.
    Steyerberg, Ewout W.
    Harkin, Tim
    Helleman, Jozien
    Roobol, Monique J.
    Frydenberg, Mark
    EUROPEAN UROLOGY ONCOLOGY, 2020, 3 (01): : 80 - 91
  • [22] Active Surveillance for Low-risk Prostate Cancer: Are All Criteria Similar?
    Cimino, Sebastiano
    Privitera, Salvatore
    Favilla, Vincenzo
    Cantiello, Francesco
    Manno, Stefano
    Cicione, Antonio
    Damiano, Rocco
    Russo, Giorgio Ivan
    Morgia, Giuseppe
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2018, 18 (07) : 958 - 963
  • [23] Variation in the use of active surveillance for low-risk prostate cancer
    Loeppenberg, Bjoern
    Friedlander, David F.
    Krasnova, Anna
    Tam, Andrew
    Leow, Jeffrey J.
    Nguyen, Paul L.
    Barry, Hawa
    Lipsitz, Stuart R.
    Menon, Mani
    Abdollah, Firas
    Sammon, Jesse D.
    Sun, Maxine
    Choueiri, Toni K.
    Kibel, Adam S.
    Quoc-Dien Trinh
    CANCER, 2018, 124 (01) : 55 - 64
  • [24] Perceived barriers to the adoption of active surveillance in low-risk prostate cancer: a qualitative analysis of community and academic urologists
    Ellis, Shellie D.
    Hwang, Soohyun
    Morrow, Emily
    Kimminau, Kim S.
    Goonan, Kelly
    Petty, Laurie
    Ellerbeck, Edward
    Thrasher, J. Brantley
    BMC CANCER, 2021, 21 (01)
  • [25] Primary Care Physician and Urologist Perspectives on Optimizing Active Surveillance for Low-Risk Prostate Cancer
    Radhakrishnan, Archana
    Subramanian, Lalita
    Rankin, Aaron J.
    Fetters, Michael D.
    Wittmann, Daniela A.
    Ginsburg, Kevin B.
    Hawley, Sarah T.
    Skolarus, Ted A.
    ANNALS OF FAMILY MEDICINE, 2024, 22 (01) : 5 - 11
  • [26] Active Surveillance for Low-Risk Localized Prostate Cancer
    Large, Michael C.
    Eggener, Scott E.
    ONCOLOGY-NEW YORK, 2009, 23 (11): : 974 - 979
  • [27] Psychological predictors of delayed active treatment following active surveillance for low-risk prostate cancer: The Patient REported outcomes for Prostate cARE prospective cohort study
    Taylor, Kathryn L.
    Luta, George
    Zotou, Vasiliki
    Lobo, Tania
    Hoffman, Richard M.
    Davis, Kimberly M.
    Potosky, Arnold L.
    Li, Tengfei
    Aaronson, David
    Van Den Eeden, Stephen K.
    BJUI COMPASS, 2022, 3 (03): : 226 - 237
  • [28] Barriers and Facilitators to the Choice of Active Surveillance for Low-Risk Papillary Thyroid Cancer in China: A Qualitative Study Examining Patient Perspectives
    Zhu, Pingting
    Zhang, Qianqian
    Wu, Qiwei
    Shi, Guanghui
    Wang, Wen
    Xu, Huiwen
    Zhang, Li
    Qian, Meiyan
    Hegarty, Josephine
    THYROID, 2023, 33 (07) : 826 - 834
  • [29] Novel Tools to Improve Patient Selection and Monitoring on Active Surveillance for Low-risk Prostate Cancer: A Systematic Review
    van den Bergh, Roderick C. N.
    Ahmed, Hashim U.
    Bangma, Chris H.
    Cooperberg, Matthew R.
    Villers, Arnauld
    Parker, Christopher C.
    EUROPEAN UROLOGY, 2014, 65 (06) : 1023 - 1031
  • [30] Selecting Active Surveillance: Decision-Making Factors for Men with a Low-Risk Prostate Cancer
    Hoffman, Richard M.
    Lobo, Tania
    Van Den Eeden, Stephen K.
    Davis, Kimberly M.
    Luta, George
    Leimpeter, Amethyst D.
    Aaronson, David
    Penson, David F.
    Taylor, Kathryn
    MEDICAL DECISION MAKING, 2019, 39 (08) : 962 - 974